Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Micro-X Ltd. (MX1) vs. Competitors

13 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:MX1Micro-X Ltd.AUD 0.03AUD 21.83M-2.03-68.13%HoldUnlock the AU:MX1 analyst price target with TipRanks PremiumAU:MX1Unlock the AU:MX1 top-analyst price target with TipRanks Premium
AU:CMPCompumedics LimitedAUD 0.24AUD 46.94M209.09-33.80%―Unlock the AU:CMP analyst price target with TipRanks PremiumAU:MX1 vs AU:CMPUnlock the AU:CMP top-analyst price target with TipRanks Premium
AU:CYCCyclopharm LimitedAUD 0.44AUD 55.32M-2.81-41.33%Moderate BuyUnlock the AU:CYC analyst price target with TipRanks PremiumAU:MX1 vs AU:CYCUnlock the AU:CYC top-analyst price target with TipRanks Premium
AU:EMVEMvision Medical Devices Ltd.AUD 1.42AUD 132.00M-15.12-20.67%Moderate BuyUnlock the AU:EMV analyst price target with TipRanks PremiumAU:MX1 vs AU:EMVUnlock the AU:EMV top-analyst price target with TipRanks Premium
AU:4DX4DMedical LtdAUD 2.26AUD 1.36B-5.7257.49%Moderate BuyUnlock the AU:4DX analyst price target with TipRanks PremiumAU:MX1 vs AU:4DXUnlock the AU:4DX top-analyst price target with TipRanks Premium
AU:IMRImricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 1.31AUD 469.83M-7.78-2.96%Strong BuyUnlock the AU:IMR analyst price target with TipRanks PremiumAU:MX1 vs AU:IMRUnlock the AU:IMR top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:MX1Micro-X Ltd.0.03-0.06-67.42%
AU:CMPCompumedics Limited0.23-0.10-28.79%
AU:CYCCyclopharm Limited0.44-0.37-45.68%
AU:EMVEMvision Medical Devices Ltd.1.42-0.37-20.67%
AU:4DX4DMedical Ltd2.260.8054.79%
AU:IMRImricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh1.31-0.04-2.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts